UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers

Cancer Science

Volumn 99, Issue 2, 2008, Pages 340-344

  Kong, Sun Young ^a   Ki, Chang Seok ^b   Yoo, Byung Chul ^b   Kim, Jong Won ^b  

^a National Cancer Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A7;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEPATITIS B; HUMAN; KOREA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; EXONS; GENOTYPE; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HEPATITIS B, CHRONIC; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 38949150723     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00693.x     Document Type: Article

References (24)

1. Hepatitis B. World Health Organization Fact Sheet No. 204 (Revised October 2000) (Website on the Internet). Geneva: World Health Organization. Available from URL: http://www.who.int/mediacentre/ factsheets/fs204/en/.
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
4. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: S294-308.
5. Fang JL, Beland FA, Doerge DR et al. Characterization of benzo (a) pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes. Cancer Res 2002; 62: 1978-86.
6. Zheng Z, Fang JL, Lazarus P. Glucuronidation: An important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 2002; 30: 397-403.
7. Strassburg CP, Kneip S, Topp J et al. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem 2000; 275: 36164-71.
8. Strassburg CP, Manns MP, Tukey RH. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 1998; 273: 8719-26.
9. Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 2001; 33: 273-97.
10. Ciotti M, Marrone A, Potter C, Owens IS. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 1997; 7: 485-95.
11. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: Functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 2000; 10: 629-44.
12. Raijmakers MT, Jansen PL, Steegers EA, Peters WH. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol 2000; 33: 348-51.
13. Strassburg CP, Nguyen N, Manns MP, Tukey RH. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 1998; 54: 647-54.
14. Strassburg CP, Strassburg A, Nguyen N, Li Q, Manns MP, Tukey RH. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem J 1999; 338: 489-98.
15. Strassburg CP, Nguyen N, Manns MP, Tukey RH. UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 1999; 116: 149-60.
16. Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 2002; 50: 851-6.
17. Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 2003; 124: 1802-8.
18. Vogel A, Kneip S, Barut A et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 2001; 121: 1136-44.
19. Wang Y, Kato N, Hoshida Y et al. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection. Clin Cancer Res 2004; 10: 2441-6.
20. Tseng CS, Tang KS, Lo HW, Ker CG, Teng HC, Huang CS. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol 2005; 100: 1758-63.
21. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-89.
22. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 2005; 76: 449-62.
23. Barrett JC, Fry B, Maller J, Daly MJ, Haploview. analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
24. Wallenstein S, Hodge SE, Weston A. Logistic regression model for analyzing extended haplotype data. Genetic Epidemiol 1998; 15: 173-81.